… malaria vaccine is considered a further important step towards reducing the disease burden.
RTS,S/AS01 is a malaria vaccine … of RTS,S/AS01 in children 5–17 months of age. Citation12 …

… malaria vaccine, which is being developed for infants and children in regions in sub-Saharan
Africa in which malaria is … prevention of malaria, which occurs in infants who have reached …

… malaria in HIV-infected children. Based on these data, we see no reason why the RTS,S/AS01
vaccine would be contraindicated in infants and children with … , recombinant vaccines [38]. …

… cases of clinical malaria over a 3–4 year period in young infants and children when administered
… Thus, the vaccine has the potential to make a substantial contribution to malaria control …

… The RTS,S/AS01 malaria vaccine might become the first malaria vaccine licensed for use
in African children. Because of the substantial geographical overlap between malaria and HIV …

… ; the vaccine showed no protection against severe malaria or … infants and children, VE waned
with time since vaccination. … of clinical malaria per 1,000 children and infants vaccinated, …

… The candidate malaria vaccine RTS,S/AS01 reduced episodes of both clinical and severe
malaria in children 5 to 17 … We studied infants 6 to 12 weeks of age recruited for the same trial. …

… In any discussion of malaria vaccines, the feasibility of vaccination in the field must be …
Notably, malaria-induced anemia is often found in younger children, but as the children age …

… malaria in children vaccinated at over 5 months of age.16 But the developers aimed to license
the vaccine for infants at ages … vaccine efficacy in infants with coadministration of other EPI …

… reactogenicity profile in our malaria exposed infants and children population to that seen
in The Gambia who received comparable doses [12,13]. The vaccines demonstrated a good …